Physician profile
Jamison Jaffe
NPI 1508966516
$5,678.72
in general payments reported to CMS, 2019-2025
43 companies · $375 in 2025
The $375 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,259 · 2020: $463 · 2021: $424 · 2022: $1,401 · 2023: $792 · 2024: $965 · 2025: $375.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,132.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,132.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,125.47 | 2021-2022 | |
| Boston Scientific Corporation | $889.05 | 2019-2025 | Lithovue, Moses 550 Dfl, General - Erectile Dysfunction |
| Astellas Pharma US INC | $872.30 | 2019-2024 | Xtandi, Myrbetriq |
| Neotract INC. | $265.56 | 2019-2020 | |
| Antares Pharma, INC. | $214.27 | 2019-2024 | Xyosted |
| Olympus America INC. | $205.86 | 2023-2025 | Soltive, Itind System, Bovie |
| Janssen Biotech, INC. | $205.04 | 2019-2025 | Erleada |
| Laborie Medical Technologies Corp. | $154.01 | 2023-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Baxter Healthcare | $123.67 | 2023-2024 | Perclot |
| Coloplast Corp | $123.23 | 2023-2024 | Altis, Porges Coloplast, Stenostent |
| Photocure INC | $118.99 | 2019-2025 | Cysview |
| Ferring Pharmaceuticals INC. | $93.99 | 2019-2024 | Adstiladrin |
| Sumitomo Pharma America, INC. | $86.69 | 2023-2025 | Gemtesa, Orgovyx |
| Medtronic, INC. | $79.29 | 2022-2025 | Interstim |
| Urogen Pharma, INC. | $73.12 | 2020-2023 | Jelmyto |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $67.93 | 2020 | |
| Axonics, INC. | $66.79 | 2022-2023 | Bulkamid |
| Aytu Biopharma, INC. | $64.97 | 2019 | |
| Pfizer INC. | $61.66 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $61.01 | 2019-2020 | |
| Stryker Corporation | $56.33 | 2024 | 1788, Fluid Management System |
| Agiliti Surgical, INC. | $52.68 | 2023 | Trinity, Sonablate |
| Calyxo, INC. | $51.83 | 2024-2025 | Cvac Aspiration System |
| Bk Medical Holding Company INC. | $47.49 | 2024 | Bk3000, Bk3500 & Bk5000 Ultrasound System |
| Myovant Sciences INC. | $43.67 | 2021-2022 | |
| Allergan, INC. | $41.99 | 2019-2020 | |
| Bluewind Medical | $40.26 | 2024 | Revi |
| Abbvie INC. | $36.47 | 2024-2025 | |
| Blue Earth Diagnostics | $35.95 | 2019-2020 | |
| Amgen INC. | $34.74 | 2019-2025 | Uplizna |
| Mission Pharmacal Company | $32.04 | 2022-2023 | |
| Integra Lifesciences Corporation | $31.26 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Verity Pharmaceuticals INC. | $31.15 | 2022-2023 | Trelstar |
| Convatec INC. | $30.94 | 2022 | |
| Medtronic USA, INC. | $27.72 | 2020 | |
| Acerus Pharmaceuticals Corporation | $18.56 | 2021 | |
| Halozyme INC | $18.19 | 2023 | |
| Novartis Pharmaceuticals Corporation | $18.00 | 2025 | |
| Endo Pharmaceuticals INC. | $17.39 | 2023 | Xiaflex |
| Progenics Pharmaceuticals, INC. | $17.39 | 2022 | |
| Merck Sharp & Dohme LLC | $15.23 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $13.33 | 2019 | |
| Cook Medical LLC | $13.21 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamison Jaffe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.